Xtx Topco LTD Mainz Biomed N.V. Put Options Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MYNZ
# of Institutions
10Shares Held
136KCall Options Held
0Put Options Held
0-
Northern Trust Corp Chicago, IL29.9KShares$212,2320.0% of portfolio
-
Two Sigma Securities, LLC New York, NY23.5KShares$166,7210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$107,6900.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$103,2230.0% of portfolio
-
Greenwich Investment Management, Inc. Stamford, CT10.9KShares$76,9900.0% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $103M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...